PRQR · NASDAQ · Biotechnology

ProQR Therapeutics (PRQR)

Develops Axiomer RNA-editing medicines, led by AX-0810 for cholestatic diseases.

$1.70
After hours+0.01 (+0.59%)
At close$1.69(−11.05%)
  1. ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates

    Zacks Investment Research